Olympus Corp. (OCPNY) Lowered to Hold at Zacks Investment Research
Olympus Corp. (OTCMKTS:OCPNY) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Friday.
According to Zacks, “OLYMPUS CORPORATION is a Japan-based company. The Company is engaged in the manufacturing and selling of precision machineries and instruments. The businesses of the Company include Imaging System Business, Medical Systems Business, Life Science Business, Information and Communication Business, and Others Business. Olympus has always been a company that makes people’s dreams come true through innovative products. Olympus cameras have always been at the leading edge of innovation. “
Shares of Olympus Corp. (OTCMKTS:OCPNY) opened at 33.59 on Friday. The firm has a 50-day moving average price of $36.65 and a 200 day moving average price of $36.79. The firm has a market capitalization of $11.50 billion, a price-to-earnings ratio of 16.03 and a beta of 1.10. Olympus Corp. has a 12 month low of $31.50 and a 12 month high of $39.49.
COPYRIGHT VIOLATION NOTICE: This story was first published by Watch List News and is owned by of Watch List News. If you are accessing this story on another site, it was copied illegally and reposted in violation of U.S. and international copyright & trademark law. The original version of this story can be viewed at https://www.watchlistnews.com/olympus-corp-ocpny-lowered-to-hold-at-zacks-investment-research/1471675.html.
About Olympus Corp.
Olympus Corporation is engaged in the manufacture and sale of precision machineries and instruments. The Company’s segments include Medical Business, Scientific Solutions Business, Imaging Business and Others. The Company’s Medical Business manufactures and sells medical endoscopes, surgical endoscopes, endotherapy devices and other products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Olympus Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Olympus Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.